Dark Forest Capital Management LP Dexcom Inc Transaction History

Dark Forest Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $233,825 - $272,307	2,079 New	2,079 $267,000
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $3,909 - $5,642	46 Added 511.11%	55 $6,000
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $76 - $94	1 Added 12.5%	9 $1,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $543 - $1,063	8 New	8 $1,000
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $5,832 - $8,072	-62 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $7,272 - $9,117	-56 Reduced 47.46%	62 $33,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $12,591 - $16,895	118 New	118 $65,000

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.